日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

YAP1 defines an emergent, plastic population of relapsed small cell lung cancer

YAP1定义了复发性小细胞肺癌中一种新兴的、可塑性的细胞群。

Stewart, C Allison; Ramkumar, Kavya; Wang, Runsheng; Xi, Yuanxin; Halliday, Alexa; Diao, Lixia; Wang, Qi; Serrano, Alejandra; Groves, Sarah; Heeke, Simon; Tanimoto, Azusa; Kaiser, Laura; Lewis, Whitney; Bose, Mukulika; Da Rocha, Pedro; Karacosta, Loukia; Quaranta, Vito; Wang, Jing; George, Julie; Solis Soto, Luisa Maren; Zhang, Bingnan; Heymach, John V; Byers, Lauren A; Gay, Carl M

The Impact of Targeting TRAF2 and NCK-Interacting Protein Kinase on Antitumor Effect and Tumor Immune Environment in c-MYC-High SCLC

靶向TRAF2和NCK相互作用蛋白激酶对c-MYC高表达小细胞肺癌抗肿瘤效应和肿瘤免疫微环境的影响

Tanimoto, Azusa; Ramkumar, Kavya; Stewart, C Allison; Zhang, Bingnan; Concannon, Kyle; Cardnell, Robert J; Shen, Li; Wang, Qi; Wang, Jing; Gay, Carl M; Byers, Lauren Averett

YAP1 defines an emergent, plastic population of relapsed small cell lung cancer.

YAP1 定义了复发性小细胞肺癌中一种新兴的、可塑性强的细胞群。

Stewart C Allison, Ramkumar Kavya, Wang Runsheng, Xi Yuanxin, Halliday Alexa, Diao Lixia, Wang Qi, Serrano Alejandra, Groves Sarah, Heeke Simon, Tanimoto Azusa, Kaiser Laura, Lewis Whitney, Bose Mukulika, Da Rocha Pedro, Karacosta Loukia, Quaranta Vito, Wang Jing, George Julie, Solis Soto Luisa Maren, Zhang Bingnan, Heymach John V, Byers Lauren A, Gay Carl M

YAP1 Status Defines Two Intrinsic Subtypes of LCNEC with Distinct Molecular Features and Therapeutic Vulnerabilities.

YAP1 状态定义了 LCNEC 的两种内在亚型,它们具有不同的分子特征和治疗脆弱性

Stewart C Allison, Diao Lixia, Xi Yuanxin, Wang Runsheng, Ramkumar Kavya, Serrano Alejandra G, Tanimoto Azusa, Rodriguez B Leticia, Morris Benjamin B, Shen Li, Zhang Bingnan, Yang Yan, Hamad Samera H, Cardnell Robert J, Duarte Alberto Jr, Sahu Moushumi, Novegil Veronica Y, Weissman Bernard E, Frumovitz Michael, Kalhor Neda, Solis Soto Luisa, da Rocha Pedro, Vokes Natalie, Gibbons Don L, Wang Jing, Heymach John V, Glisson Bonnie, Byers Lauren Averett, Gay Carl M

Multi-institutional survey of malignant pleural mesothelioma patients in the Hokushin region

北新地区恶性胸膜间皮瘤患者的多中心调查

Uramoto, Hidetaka; Takiguchi, Tomoya; Koizumi, Tomonobu; Tanimoto, Azusa; Hayashi, Ryuji; Nakazawa, Yozo; Ito, Ken-Ichi; Nakada, Mitsutoshi; Hirono, Yasuo; Nishino, Yoshikazu; Yano, Seiji

Multi-institutional survey of thymic carcinoma patients in Hokushin region

北信地区胸腺癌患者的多中心调查

Uramoto, Hidetaka; Takiguchi, Tomoya; Koizumi, Tomonobu; Tanimoto, Azusa; Hayashi, Ryuji; Nakazawa, Yozo; Ito, Ken-Ichi; Nakada, Mitsutoshi; Hirono, Yasuo; Nishino, Yoshikazu; Yano, Seiji

Clinical efficacy of dacomitinib in rechallenge setting for patients with epidermal growth factor receptor mutant non-small cell lung cancer: A multicenter retrospective analysis (TOPGAN2020-02)

达克替尼在表皮生长因子受体突变型非小细胞肺癌患者再次治疗中的临床疗效:一项多中心回顾性分析(TOPGAN2020-02)

Tanaka, Hisashi; Sakamoto, Hiroaki; Akita, Takahiro; Ohyanagi, Fumiyoshi; Kawashima, Yosuke; Tambo, Yuichi; Tanimoto, Azusa; Horiike, Atsushi; Miyauchi, Eisaku; Tsuchiya-Kawano, Yuko; Yanagitani, Noriko; Nishio, Makoto

Severe Skin Toxicity Caused by Sequential Anti-PD-1 Antibody and Alectinib in Non-small-cell Lung Cancer: A Report of Two Cases and a Literature Review

非小细胞肺癌患者序贯使用抗PD-1抗体和阿来替尼治疗引起严重皮肤毒性:两例病例报告及文献综述

Nishiyama, Akihiro; Hattori, Yoshihiro; Takeuchi, Shinji; Tanimoto, Azusa; Satouchi, Miyako; Murayama, Toshinori; Yano, Seiji

Mediastinal Malignant Melanoma Markedly Shrinking in Response to Nivolumab

纵隔恶性黑色素瘤对纳武利尤单抗治疗反应显著缩小

Sakaguchi, Hiroyuki; Tanimoto, Azusa; Sato, Shigeki; Yanagimura, Naohiro; Suzuki, Chiaki; Takumi, Yohei; Nishiyama, Akihiro; Yamashita, Kaname; Takeuchi, Shinji; Ohtsubo, Koshiro; Yano, Seiji

Methylation of Tumor Suppressive miRNAs in Plasma from Patients With Pancreaticobiliary Diseases

胰胆疾病患者血浆中抑癌miRNA的甲基化

Ohtsubo, Koushiro; Miyake, Kunio; Arai, Sachiko; Fukuda, Koji; Suzuki, Chiaki; Kotani, Hiroshi; Tanimoto, Azusa; Nishiyama, Akihiro; Nanjo, Shigeki; Yamashita, Kaname; Takeuchi, Shinji; Yano, Seiji